Journal
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
Volume 459, Issue 6, Pages 1005-1013Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00424-010-0822-4
Keywords
Endothelium; Endothelium-derived relaxing factor (EDRF); Nitric oxide; Prostacyclin; Endothelium-derived hyperpolarizing factor
Categories
Funding
- Swiss National Science Foundation [3100-068118, 310030-118353]
- Mercator
- Bonizi-Theler
- Swiss Heart Foundation
Ask authors/readers for more resources
Since the detection of nitric oxide two and a half decades ago, there has been an incredible boost in endothelial function research, which is fascinating the research community. Physiologically, endothelial cells synthesize a number of vasoactive substances. In particular, several endothelium-derived relaxing factors (EDRFs) have been characterized, whereby nitric oxide is the most important. In humans, endothelial dysfunction is one of the first clinically detectable alterations in the development of atherosclerosis and is characterized by an imbalance in the release of vasoactive substances. Thus, it is the aim of this article to give an overview about endothelial function in humans, to summarize the different possibilities to assess endothelial function in this species, and to give an overview of the role of EDRFs in different cardiovascular diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available